Women, Infants, and Children (WIC) infant formula rebate - Soy

Abbott Laboratories has been awarded contract X041792 by the New York Department of Health, effective October 1, 2026, through September 30, 2031. The five-year contract carries a cumulative value of $10.8 million. However, the specific products and services to be delivered under this agreement are not detailed in the available contract documentation.

Without additional specification sheets, statement of work documentation, or procurement details, the precise nature of Abbott Laboratories' deliverables cannot be determined from the information provided. Given Abbott Laboratories' diverse portfolio spanning diagnostics, pharmaceuticals, medical devices, and nutritional products, the contract could encompass multiple service or product categories within the Department of Health's operational scope. Interested parties seeking detailed information regarding contract scope, performance locations, and service specifications should consult the complete contract documentation or contact the New York Department of Health directly.